drugset / Trial / NCT05222256

Comparison Between Levosimendan and Adrenaline in CABG Patients

NCT05222256

Completed 60 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to compare between levosimendan and adrenaline in patients with pre-existing impaired systolic function (EF 30-40%), undergoing elective on-pump CABG, as regards hemodynamics and echocardiographic parameters.

Timeline

Start
2022-03-25
Primary completion
2024-03-29
Completion
2024-05-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Epinephrine Other / unclassified 0.05 ug/kg
Subject Levosimendan Other / unclassified 0.1 ug/kg

Indications

No indication recorded.